Remote patient monitoring with automated peritoneal dialysis linked to lower mortality
Click Here to Manage Email Alerts
Key takeaways:
- Patients on automated peritoneal dialysis-remote patient monitoring had a lower mortality rate.
- Patients had a greater improvement in technique survival.
Use of remote patient monitoring programs in adults on automated peritoneal dialysis may be connected to better survival of the technique and lower mortality rates, according to a recently published study.
PD is a “continuous, safe, home-based and cost-effective treatment for patients with end-stage renal disease, with similar or better clinical outcomes than in-center hemodialysis,” Francisco Javier Centellas-Pérez, MD, of the Albacete General University Hospital in Albacete, Spain, wrote with colleagues. “Patients still require periodic hospital visits to receive a full assessment of treatment adequacy.”
In a prospective, multicenter cohort study of 232 patients with automated peritoneal dialysis (APD) at 16 Spanish hospitals in 2021, researchers evaluated standardized outcomes in nephrology in peritoneal dialysis (SONG-PD) clinical outcomes. Patients were categorized into two groups with 176 patients in the APD-remote patient monitoring (RPM) group and 56 in the APD-without-RPM group.
PD-associated infection, cardiovascular disease, mortality rate, technique survival and health-related quality of life were primary endpoints.
Patients in the APD-RPM group had a lower mortality rate and greater improvement in technique survival vs. those in the APD-without-RPM group, according to the findings. After propensity score matching, APD-RPM remained associated with better technique survival.
“Although in the overall population, the use of RPM programs in patients on APD was associated with lower mortality rate, such findings were not observed after PSM,” the researchers wrote. “RPM programs could be a safe and effective strategy for improving PD technique survival. Despite the promising results of the current study, randomized clinical trials using SONG-PD outcomes are needed to confirm these findings.”